当前位置: 首页 > 期刊 > 《中国医药导报》 > 2014年第31期
编号:1601420
他克莫司联合糖皮质激素治疗特发性膜性肾病的临床效果
http://www.100md.com 2014年12月15日 中国医药导报 2014年第31期
     侯终君

    [摘要] 目的 观察他克莫司联合糖皮质激素治疗特发性膜性肾病的临床效果。 方法 选取辽宁省盘锦市中心医院2011年3月~2013年3月收治入院的特发性膜性肾病患者68例,并将其随机分为治疗组与对照组,各34例。两组患者均给予泼尼松片mmol/L、(4.01±0.96)mmol/L]比较,差异均有统计学意义(均P 0.05)。 结论 他克莫司联合糖皮质激素是治疗特发性膜性肾病的有效手段,值得临床推广应用。

    [关键词] 他克莫司;糖皮质激素;特发性膜性肾病;效果

    [中图分类号] R692.3 [文献标识码] A [文章编号] 1673-7210(2014)11(a)-0069-04

    Clinical effect of Tacrolimus combined with glucocorticoids in the treatment of idiopathic membranous nephropathy

    HOU Zhongjun

    Department of Nephrology, Panjin Central Hospital, Liaoning Province, Panjin 124000, China

    [Abstract] Objective To observe the clinical effect of Tacrolimus combined with glucocorticoids in the treatment of idiopathic membranous nephropathy. Methods 68 cases of patients with idiopathic membranous nephropathy admitted to Panjin Central Hospital from March 2011 to March 2013 were chosen and randomly divided into two groups: treatment group and control group, with 34 cases in each group. The patients of both groups were given Prednisone Tablets 0.5 mg/(kg·d) orally, decreasing to 10 mg/d gradually and keep taking. On this basis, the treatment group was given Tacrolimus ......

您现在查看是摘要页,全文长 18873 字符